Three physicians at the Center for Human Reproduction (CHR) in New York City, one of the world's leading clinical fertility and research centers, developed What's My Fertility. They and our advisory board, consisting of leading academics involved in the clinical and social aspects of infertility, are united in their passion for helping women overcome infertility. Our physicians and advisory board members work together to make POA risk screening a routine part of women’s health so no woman has to suffer through the disappointment of infertility due to POA (premature ovarian aging).
Norbert Gleicher, MD
A world-renowned researcher on infertility, CHR's Medical Director and Chief Scientist, Norbert Gleicher, MD, has published extensively on female reproduction, autoimmunity and fertility, endometriosis, low functional ovarian reserve, and other difficult-to-treat infertility problems.
Dr. Gleicher graduated from Tel Aviv University Sackler School of Medicine in Israel. After completion of his residency training and fellowship in reproductive immunology at Mount Sinai Medical Center in New York City, he held various medical and administrative positions at some of the best hospitals and universities in the US. In 1981, Dr. Gleicher founded the Center for Human Reproduction (CHR), where he is currently Medical Director and Chief Scientist. As a consequence of CHR’s evolving scientific collaboration with The Rockefeller University, New York, N.Y., Dr. Gleicher was appointed Professor (Adj.) at the university in May 2015.
Dr. Gleicher has published hundreds of peer-reviewed scientific papers, abstracts and book chapters, as well as edited textbooks and served as editor for many specialty journals. His editorial roles have included founding Editor-in-Chief for the American Journal of Reproductive Immunology (AJRI) and the Journal of In Vitro Fertilization and Embryo Transfer (renamed Journal of Assisted Reproduction and Genetics in 1992). Currently, he serves as Academic Editor for PLoS ONE , and is a member of multiple editorial boards.
In 2009, he was invited to give the prestigious Patrick Steptoe Memorial Lecture to the British Fertility Society, in recognition of his lifelong contribution to the advancements in reproductive endocrinology and infertility. A popular speaker at worldwide conferences, Dr. Gleicher travels extensively while maintaining his role in clinical patient care and research at CHR. He has been repeatedly one of a handful of reproductive endocrinologists in New York City listed by the New York Times Magazine on its “Super Doctors” list, as chosen by peers.
David H. Barad, MD, MS
CHR's Director of Clinical ART and Senior Scientist, David H. Barad, MD, MS, specializes in reproductive endocrinology and infertility and has played an active role in clinical research in the field.
Dr. Barad is a graduate of Rutgers Medical School and completed his residency in OB/GYN at the Sloane Hospital for Women of Columbia Presbyterian Medical Center in New York. Following his residency, Dr. Barad was accepted to the Fellowship in reproductive endocrinology and infertility at the Brigham and Women's Hospital of Harvard Medical School, Boston. Dr. Barad is certified as a Diplomate of the American College of Obstetrics and Gynecology and also received subspecialty certification as a reproductive endocrinologist. Dr. Barad served as Director of Reproductive Endocrinology and Infertility at Montefiore Medical Center and Albert Einstein College of Medicine. Currently, Dr. Barad holds the academic title of Associate Clinical Professor at Albert Einstein College of Medicine.
Dr. Barad has been active in clinical research. He served as an investigator at the New York Clinical Center of the Women's Health Initiative (WHI) on the landmark study examining factors that may affect the health of women after menopause. He is currently a scientific consultant for the WHI, and was Chair of the WHI Hormone Trials advisory committee during the active phases of the study.
Dr. Barad has published extensively in the field of reproductive endocrinology. He is a fellow of the American College of Obstetrics and Gynecology, a member of the American Society of Reproductive Medicine and of the Society of Reproductive Endocrinology, as well as numerous other professional societies and organizations.
In May 2003 Dr. Barad was awarded a Masters of Science degree in Clinical Research Methods at the Albert Einstein College of Medicine. In 1999 he was recognized by the American Infertility Association for his "continuing dedication and support to individuals experiencing infertility".
Vitaly A. Kushnir, MD
With a research interest in ovarian physiology as well as roles of antioxidants and mitochondria in oocyte development, CHR's Associate Scientist and Reproductive Endocrinology Physician Vitaly A. Kushnir, MD, has in recent years contributed extensively to CHR's research on ovarian aging.
Dr. Kushnir pursued medical school at the New York Program of Sackler School of Medicine at Tel-Aviv University in Israel. He returned to the U.S. for a residency in the Department of Obstetrics, Gynecology and Women's Health at UMDNJ – New Jersey Medical School, where he was a recipient of Resident Research Award. After a 3-year fellowship in reproductive endocrinology and infertility at Emory University in Atlanta, GA, Dr. Kushnir joined CHR in July 2012. As Director of Continuing Medical Education, Dr. Kushnir leads CHR's visiting scholar program. Dr. Kushnir also serves as Director of CHR's Fertility Preservation Center and Assistant Professor of Obstetrics and Gynecology at Wake Forest University in Winston-Salem, NC.
Dr. Kushnir is an active member of the American Society of Reproductive Medicine, Society for Gynecologic Investigation and American College of Obstetrics and Gynecology, where he served as Junior Fellow Chair in its New Jersey Section between 2006 and 2008. Dr. Kushnir has been a recipient of numerous research awards, including the Excellence in Research by a Fellow, awarded by Emory University in 2012 for his research in the role of mitochondria in female reproductive aging.
Dr. Kushnir has published numerous peer-reviewed articles and abstracts, with a keen focus on ovarian physiology and aging.
He is also a vocal advocate for reform of IVF outcome reporting systems of the CDC (for which he consults) and SART, to ensure that patients have access to accurate and transparent data regarding performance of IVF centers. In addition to presenting at multiple professional society meetings, Dr. Kushnir has also authored many book chapters on topics in obstetrics and gynecology, as well as reproductive endocrinology and infertility.Back To Top
Pasquale Patrizio, MD, MBE, HCLD
Advisory Board Chairman
Professor of Obstetrics and Gynecology and Director, Yale University Fertility Center and Fertility Preservation Program
Dr. Patrizio is a board certified specialist in obstetrics & gynecology, reproductive endocrinology and infertility and andrology. Dr. Patrizio has lectured throughout the world on the topics of in vitro fertilization (IVF), male infertility and ICSI and fertility preservation garnering a number of awards. Dr. Patrizio is an associate editor for Journal of Assisted Reproduction and Genetics and member of the editorial board of the American Journal of Obstetrics and Gynecology, Fertility and Sterility and Reproductive Biomedicine Online . He serves as reviewer for many scientific journals including Lancet, Human Reproduction and Fertility and Sterility, and is a reviewer for NIH grants .
Dr. Patrizio has authored 3 books, one being the textbook/atlas Assisted Reproductive Technologies (ART) which has been translated also into Spanish and Chinese, and two e-books (in assisted reproduction) in addition to 397 scientific papers, including 62 book chapters, 143 peer-review publications and 213 abstracts. He is the president of the International Society for Fertility Preservation (January 2015-December 2016), Clinical Director of SART and is board member of the ISMAAR. His current clinical interests include improving the efficiency of assisted reproduction technology (ART), reducing the risk of multiple pregnancy, fertility preservation strategies and methods to simplify the clinical and laboratory aspect of IVF.
Ali H. Brivanlou, PhD
Advisory Board Member
Robert and Harriet Heilbrunn Professor, Laboratory of Stem Cell Biology and Molecular Embryology, Rockefeller University
After receiving a master’s degree from the Université des Sciences du Languedoc in Montpellier, France, Dr. Brivanlou went on to earn a PhD in molecular biology from the University of California at Berkeley, in 1990, and then moved to Harvard University as a postdoctoral fellow in the laboratory of Dr. Douglas Melton. He joined the Rockefeller faculty in 1994, was appointed a professor in 2000, and was named the Heilbrunn Professor in 2007. Since 2012, he has also held an adjunct position at Columbia University, where he teaches workshops about Vital Design—Embryology, Architecture, and Innovation. Dr. Brivanlou has received a Presidential Early Career Award for Scientists, a Klingenstein Fellowship, a Searle Scholar Award, and numerous other honors. He is a member of the Scientific and Medical Research Funding Working Group of the California Institute for Regenerative Medicine (CIRM), California’s stem cell agency.
Sarah L. Berga, MD
Advisory Board Member
Chair, Obstetrics & Gynecology and Professor, Obstetrics & Gynecology, Hypertension and Vascular Research Center, Office of Women in Medicine and Science, Center for Comparative Medicine Research and Translational Science Institute
Dr. Berga is the Frank R. Lock Professor and Chair of Obstetrics and Gynecology and Executive Director of Women’s Health Services at Wake Forest School of Medicine at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. As ED, she is developing and implementing a strategic plan for the center’s clinical portfolio in obstetrics, gynecology, women’s health, and gender medicine. She fosters basic and translational research in areas relevant to reproductive and women’s health, including the biology of sex differences. Dr. Berga is specialty certified in obstetrics and gynecology and subspecialty certified in reproductive endocrinology and infertility (REI) and cares for patients with amenorrhea, infertility, menopause, and related conditions.
As an Echols Scholar at the University of Virginia, she studied the contribution of sex hormones to human behavior, sexual dimorphism, and gender asymmetry. She received her MD from the University of Virginia, completed a residency in obstetrics and gynecology at Harvard Medical School, and a fellowship in REI at UCSD. Her career experience includes administration, research, clinical care, and educational roles and activities. From 2003-2010, she chaired the Department of Gynecology and Obstetrics at Emory University. Prior to Emory, she was a tenured Professor of Obstetrics, Gynecology and Reproductive Sciences and Psychiatry at the University of Pittsburgh and Senior Scientist at Magee-Women’s Research Institute (MWRI). She helped to found the MWRI in 1990, and directed the clinical research program, serving as the Medical Director of the Magee-Women’s Clinical Research Center from 1990 to 2003.
Her research foci include neuroendocrine mechanisms mediating stress-induced reproductive compromise and the impact of sex hormones upon brain health using neuroimaging in human and nonhuman primate models. Her team pioneered the use of cognitive behavior therapy for stress-induced infertility. She was a Women’s Health Investigator from 1993-2003. Her contributions include over 130 peer-reviewed publications, over 80 book chapters, and over 20 consecutive years on NIH study section. She received the SGI Presidential Achievement Award and the Berthold Medal of the Deutsche Gesellschaft für Endokrinologie (German Endocrine Society). Leadership roles include President of the Society for Gynecological Investigation (2012-2013) and Society of Humanism in Medicine and Board of Directors of Emory Healthcare, University of Pittsburgh Physicians, American Society of Reproductive Medicine, and the International Society of Gynecologic Endocrinology.Back To Top
Marcia Inhorn, PhD
Advisory Board Member
William K. Lanman Jr. Professor of Anthropology and International Affairs, Yale University
Dr. Inhorn is the William K. Lanman Jr. Professor of Anthropology and International Affairs at Yale University. A medical anthropologist focusing on gender and health issues, Dr. Inhorn has conducted numerous research projects on the social impact of infertility and the emergence of assisted reproductive technologies to overcome both male and female infertility. She is the author of five books on the subject, including her most recent, Cosmopolitan Conceptions: IVF Sojourns in Global Dubai (Duke University Press, 2015), which focuses on global reproductive travel. She is also (co)editor of nine volumes, and the author of nearly 150 scholarly articles and book chapters. Dr. Inhorn is the founding editor of the Journal of Middle East Women’s Studies (JMEWS) , and co-editor (with Soraya Tremayne) of Berghahn’s “Fertility, Reproduction, and Sexuality” book series. Dr. Inhorn has served as President of the Society for Medical Anthropology, and has received numerous awards from the American Anthropological Association.
David B. Seifer, MD
Advisory Board Member
Director of Division of Reproductive Endocrinology and Infertility
Dr. Seifer serves as the Director of the Division of Reproductive Endocrinology & Infertility and as a Professor of Obstetrics & Gynecology at the Oregon Health & Science University (OHSU). Dr. Seifer received his medical degree from the University of Illinois (Chicago) Medical School and completed his residency in obstetrics and gynecology at Stanford University Medical Center. He subsequently completed a fellowship in reproductive endocrinology and infertility at the Yale University School of Medicine.
Dr. Seifer is a consultant for the Food and Drug Administration and has published over 135 medical studies published in peer-reviewed journals. He has served as a member of the National Institutes of Health (NIH) study sections. His continuing research has focused upon the biology of ovarian function, particularly on the biological basis of the aging ovary. His sustained translational research efforts have resulted in a better understanding of normal and abnormal follicular development during ART and identifying novel human ovarian growth factors (ie. neurotrophins, inhibin B and AMH) which have informed the practice of reproductive medicine.
Lynn M. Westphal, MD
Advisory Board Member
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center
Dr. Westphal graduated summa cum laude from Lawrence University, earned her MD degree at Stanford University, and did her residency training in obstetrics and gynecology at UCLA and Stanford University. She did a fellowship in molecular biology at Stanford niversity, and completed her fellowship in reproductive endocrinology and infertility (REI) at UCSF.
Dr. Westphal joined the full-time faculty at Stanford University in 1998 and is a Professor in the Department of Gynecology and Obstetrics, Director of the Fertility Preservation and Third Party Reproduction Programs, Director of the REI Fellowship, and Co-Director of the Women’s Health and Sex Differences Scholarly Application. Her interest in fertility preservation for cancer survivors led her to set up one of the first oocyte cryopreservation programs in the country in 1999. She was the Director of Women’s Health at Stanford from 2005-2012. In 2012, she co-founded the Stanford Center for Health Research on Women and Sex Differences in Medicine (WSDM).Back To Top